In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flexus Biosciences Inc.

Division of Bristol-Myers Squibb Co.
www.flexusbio.com

Latest From Flexus Biosciences Inc.

Gilead Partnership With Arcus Brings PD-1, TIGIT Assets To Its IO Portfolio

The 10-year partnership brings Arcus up-front funding with ample earnout opportunities, while Gilead gets extensive opt-in rights and an equity stake it can increase – and potentially a wholly owned dual checkpoint combination.

Deals ImmunoOncology

Clinical Trials In Review: Big Hits And Misses In 2018

Scrip looks back at the studies released in 2018 and highlights trials that had a large impact, for better or worse.

Clinical Trials Approvals

A Wake For IDO: Bristol Ends Registrational Trials Of High-Priced Flexus Drug

Following termination of pivotal trials in three tumor types testing its in-house IDO inhibitor BMS-986205, Bristol says it is "working quickly" to assess the development of Opdivo with Incyte's epacadostat.

ImmunoOncology Clinical Trials

Incyte/Merck's ECHO-301 Failure Casts More Shadow On IDO Space

Following failure of Incyte/Merck's epacadostat/Keytruda study, NewLink Genetics says it is reviewing its IDO clinical programs.

ImmunoOncology Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bristol-Myers Squibb Co.
  • Senior Management
  • Terry Rosen, PhD, CEO
    Juan Jaen, PhD, Pres, Head, R&D
    Yujiro Hata, COO
    Jordan Fridman, PhD, CSO
  • Contact Info
  • Flexus Biosciences Inc.
    Phone: (650) 489-9000
    75 Shoreway Rd.
    Ste. D
    San Carlos, CA 94070
    USA
UsernamePublicRestriction

Register